ArticleMolecules (Basel, Switzerland)2022

Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF

Elisabetta Marini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.